Entrada Therapeutics logo

Entrada Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States201-500 Employees

Entrada Therapeutics is a Boston-based biotechnology company focused on developing genetic medicines capable of engaging intracellular targets that have historically been difficult to reach. Through proprietary, modular approaches, it is assembling a development portfolio aimed at neuromuscular and inherited retinal diseases, among other conditions. The firm’s lead programs include strategies to address Duchenne muscular dystrophy by exon skipping, reflecting its focus on intracellular genetic modulation.
Based in Boston, Massachusetts, the company operates as a clinical-stage biopharmaceutical firm addressing unmet needs in genetic diseases with limited treatment options. In 2026, Entrada announced progress on VX-670, a clinical-stage program for myotonic dystrophy type 1 that is being developed through a partnership.

Find Entrada Therapeutics employees' phone numbers or email addresses

Entrada Therapeutics Global Highlights

Location
Employees

North America
215

Minus sign iconPlus sign icon
  • United States Of America
    215

Europe
3

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Spain
    1
  • Italy
    1

Africa
1

Minus sign iconPlus sign icon
  • Algeria
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Entrada Therapeutics's Leadership

  • Managing Broker And Owner at Entrada Therapeutics
    C. P.
    Managing Broker And Owner
  • Sr Director Of Regulatory Affairs at Entrada Therapeutics
    X. W.
    Sr Director Of Regulatory Affairs
  • Clinical Development Liaison, Associate Director at Entrada Therapeutics
    A. S.
    Clinical Development Liaison, Associate Director
  • Sn Manager, Glp Qa at Entrada Therapeutics
    D. P.
    Sn Manager, Glp Qa
  • Clinical Development Liaison, Associate Director | Dmd | Amplity For Entrada Therapeutics at Entrada Therapeutics
    C. P.
    Clinical Development Liaison, Associate Director | Dmd | Amplity For Entrada Therapeutics
  • Manager, Qa Gmp at Entrada Therapeutics
    K. C.
    Manager, Qa Gmp
  • Responsable De Service at Entrada Therapeutics
    M. K.
    Responsable De Service
  • Senior Scientist at Entrada Therapeutics
    G. W.
    Senior Scientist

Entrada Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Human Resources
  • Analytics
  • Biotechnology
  • Other
  • Finance
  • Recruiting
  • Engineering
  • Business
  • Legal
  • Accounting
  • Administrative

Contact profiles from Entrada Therapeutics

Name
Title
Contact
Location
Last Update
  • Managing Broker And Owner at Entrada Therapeutics
    C. P.
    Managing Broker And Owner
    Oct 16, 2024
  • Sr Director Of Regulatory Affairs at Entrada Therapeutics
    X. W.
    Sr Director Of Regulatory Affairs
    Sep 18, 2026
  • Clinical Development Liaison, Associate Director at Entrada Therapeutics
    A. S.
    Clinical Development Liaison, Associate Director
    United Kingdom
    Oct 19, 2026
  • Sn Manager, Glp Qa at Entrada Therapeutics
    D. P.
    Sn Manager, Glp Qa
    Oct 18, 2026
  • Clinical Development Liaison, Associate Director | Dmd | Amplity For Entrada Therapeutics at Entrada Therapeutics
    C. P.
    Clinical Development Liaison, Associate Director | Dmd | Amplity For Entrada Therapeutics
    Italy, Tuscany
    Sep 08, 2026
  • Manager, Qa Gmp at Entrada Therapeutics
    K. C.
    Manager, Qa Gmp
    Aug 04, 2026
  • Responsable De Service at Entrada Therapeutics
    M. K.
    Responsable De Service
    Algeria, Tiaret
    Sep 12, 2025
  • Senior Scientist at Entrada Therapeutics
    G. W.
    Senior Scientist
    Jun 22, 2026
  • Senior Research Associate at Entrada Therapeutics
    S. A.
    Senior Research Associate
    May 12, 2025
  • Scientist Ii at Entrada Therapeutics
    T. D.
    Scientist Ii
    Sep 12, 2023

Frequently Asked Questions

What is Entrada Therapeutics known for?

Minus sign iconPlus sign icon
Entrada Therapeutics was founded in 2016 and operates in the Biotechnology Research industry. Explore Entrada Therapeutics's company overview page for more information.

What is Entrada Therapeutics's most common email format?

Minus sign iconPlus sign icon
Entrada Therapeutics employees' email format typically follows the pattern of FLast@entradatx.com. Trying to find reliable and up-to-date employee contact data? Find more Entrada Therapeutics email formats with LeadIQ.

How many employees does Entrada Therapeutics have currently?

Minus sign iconPlus sign icon
Entrada Therapeutics has approximately 203 employees as of October 2026. These team members are located across 5 continents, including North America, Europe and Africa.

Who are Entrada Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Entrada Therapeutics's key employees include:

  • Managing Broker And Owner: C. P.
  • Sr Director Of Regulatory Affairs: X. W.
  • Clinical Development Liaison, Associate Director: A. S.
  • Sn Manager, Glp Qa: D. P.
  • Clinical Development Liaison, Associate Director | Dmd | Amplity For Entrada Therapeutics: C. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.